FDA Inspection 668329 — Temmler Pharma GmbH & Co. KG

Temmler Pharma GmbH & Co. KG — FEI 3002808339

The FDA completed an inspection of Temmler Pharma GmbH & Co. KG on May 27, 2010 in Marburg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 27, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Marburg (Germany)